ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MPH Mereo Biopharma Group Plc

26.50
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mereo Biopharma Group Plc LSE:MPH London Ordinary Share GB00BZ4G2K23 ORD GBP0.003 (REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 26.50 26.00 27.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Mereo BioPharma Group plc Holding(s) in Company (7478D)

28/04/2017 3:37pm

UK Regulatory


TIDMMPH

RNS Number : 7478D

Mereo BioPharma Group plc

28 April 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
---------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                  Mereo BioPharma Group plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------  --------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
---------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                               X 
------------------------------------------------------------  -------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------  -------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------  -------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------  -------------------------- 
 Other (please 
  specify): 
----------------------------------------------------------    -------------------------- 
 3. Full name of person(s)                                            Novartis Pharma AG 
  subject to the 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  --------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
-----------------------------------------------------------  --------------------------- 
 5. Date of the transaction                                                27 April 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  --------------------------- 
 6. Date on which issuer                                                   27 April 2017 
  notified: 
-----------------------------------------------------------  --------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                                                 19% 
-----------------------------------------------------------  --------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                   Resulting situation after the 
  of             to the triggering                    triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  -----------------------------------  ------------------------------------------------------------------ 
                Number            Number             Number          Number of                % of voting 
                 of                of                 of shares       voting                   rights (x) 
                 Shares            Voting                             rights 
                                   Rights 
-------------  ----------------  -----------------  --------------  -----------------------  ------------------------- 
                                                     Direct          Direct     Indirect      Direct        Indirect 
                                                                     (xi)        (xii) 
-------------      ------------    -------------    --------------  ---------  ------------  ------------  ----------- 
 Ordinary 
 shares 
 of GBP0.03 
 each 
 
 GB00BZ4G2K23   12,546,480        18.1%              13,767,841                               19.5% 
               ----------------  -----------------  --------------  ---------  ------------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration      Exercise/                          Number of voting           % of voting 
 financial           date            Conversion                         rights that                rights 
 instrument          (xiii)          Period (xiv)                       may be 
                                                                        acquired if 
                                                                        the 
                                                                        instrument 
                                                                        is 
                                                                        exercised/ 
                                                                        converted. 
-----------------  --------------  ---------------------------------  -------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise        Expiration       Exercise/         Number of voting           % of voting 
 financial         price          date             Conversion         rights instrument          rights (xix, 
 instrument                       (xvii)           period             refers to                  xx) 
                                                   (xviii) 
---------------  --------------  ---------------  ----------------  -------------------------  ----------------------- 
                                                                                                Nominal       Delta 
---------------  --------------  ---------------  ----------------  -------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                               Percentage of voting rights 
----------------------------------------------------  ---------------------------------------------------------------- 
 13,767,841                                            19.5% 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
--------------------------------------------------------------------------------- 
 
 
 Proxy Voting: 
--------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------  ------------------ 
 11. Number of voting rights proxy 
  holder will cease to hold: 
-------------------------------------------------------------  ------------------ 
 12. Date on which proxy holder will 
  cease to hold voting rights: 
-------------------------------------------------------------  ------------------ 
 
 
  13. Additional information: 
-------------------------------------------------------------  ------------------ 
 14. Contact name:                                                 Marc Ceulemans 
-------------------------------------------------------------  ------------------ 
 15. Contact telephone number:                                  00 41 61 324 5365 
-------------------------------------------------------------  ------------------ 
 
 
 
 Note: Annex should only be submitted to the FCA not 
  the issuer 
 Annex: Notification of major interests in share 
 
 A: Identity of the persons or legal entity subject to 
  the notification obligation 
-------------------------------------------------------- 
 Full name 
  (including legal form of 
  legal entities) 
------------------------------------------------------ 
 Contact address 
  (registered office for legal 
  entities) 
------------------------------------------------------ 
 Phone number & email 
------------------------------------------------------ 
 Other useful information 
  (at least legal representative 
  for legal persons) 
------------------------------------------------------ 
 
 B: Identity of the notifier, if applicable 
-------------------------------------------------------- 
 Full name 
------------------------------------------------------ 
 Contact address 
------------------------------------------------------ 
 Phone number & email 
------------------------------------------------------ 
 Other useful information 
  (e.g. functional relationship 
  with the person or legal 
  entity subject to the notification 
  obligation) 
------------------------------------------------------ 
 
 C: Additional information 
-------------------------------------------------------- 
 
 For notes on how to complete form TR-1 please see the 
  FCA website. 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLIPMITMBJTBIR

(END) Dow Jones Newswires

April 28, 2017 10:37 ET (14:37 GMT)

1 Year Mereo Biopharma Chart

1 Year Mereo Biopharma Chart

1 Month Mereo Biopharma Chart

1 Month Mereo Biopharma Chart

Your Recent History

Delayed Upgrade Clock